The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
TRANSENTERIX INC | COM NEW | 89366M201 | 15,784 | 6,631,832 | SH | OTR | 1,2 | 0 | 6,631,832 | 0 | |
OCULAR THERAPEUTIX INC | COM | 67576A100 | 2,494 | 628,236 | SH | OTR | 1,2 | 0 | 628,236 | 0 | |
CATABASIS PHARMACEUTICALS IN | COM NEW | 14875P206 | 2,263 | 285,765 | SH | OTR | 0 | 285,765 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 52,419 | 1,831,548 | SH | OTR | 1,2 | 0 | 1,831,548 | 0 | |
DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 28,739 | 1,238,198 | SH | OTR | 3,4 | 0 | 1,238,198 | 0 | |
X4 Pharmaceuticals | COM | 98420X103 | 5,423 | 311,490 | SH | OTR | 3,4 | 0 | 311,490 | 0 | |
AVROBIO INC | COM | 05455M100 | 42,572 | 1,930,704 | SH | OTR | 3,4 | 0 | 1,930,704 | 0 | |
SUTRO BIOPHARMA INC | COM | 869367102 | 20,781 | 1,824,542 | SH | OTR | 1,2 | 0 | 1,824,542 | 0 |